Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICGeneric

BACITRACIN ZINC AND POLYMYXIN B SULFATE

BACITRACIN ZINC; POLYMYXIN B SULFATE

Standard Dose
500 UNITS/GM;10,000 UNITS/GM
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BACITRACIN ZINC AND POLYMYXIN B SULFATE is listed in Drugs@FDA under application 065022 (ANDA).

Marketing status: Discontinued Active ingredient BACITRACIN ZINC; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - 500 UNITS/GM;10,000 UNITS/GM Sponsor PADAGIS US Submission history Latest submission status date: 2014-08-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview BACITRACIN ZINC AND POLYMYXIN B SULFATE is listed in Drugs@FDA under application 065022 (ANDA). Marketing status: Discontinued Active ingredient BACITRACIN ZINC; POLYMYXIN B SULFATE Form and strength OINTMENT;OPHTHALMIC - 500 UNITS/GM;10,000 UNITS/GM Sponsor PADAGIS US Submission history Latest submission status date: 2014-08-15 00:00:00. Submission type: SUPPL.

Monitoring

  • • Review priority: UNKNOWN
  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
BACITRACIN ZINC AND POLYMYXIN B SULFATE (BACITRACIN ZINC; POLYMYXIN B SULFATE) | Drug Monograph | MedicHelpline